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Amyloid deposits are proteinaceous extra-cellular ag-
gregates associated with a diverse range of disease
states. These deposits are composed predominantly of
amyloid fibrils, the unbranched, -sheet rich structures
that result from the misfolding and subsequent aggre-
gation of many proteins. In addition, amyloid deposits
contain a number of non-fibrillar components that in-
teract with amyloid fibrils and are incorporated into the
deposits in their native folded state. The influence of a
number of the non-fibrillar components in amyloid-re-
lated diseases is well established; however, the mecha-
nisms underlying these effects are poorly understood.
Here we describe the effect of two of the most important
non-fibrillar components, serum amyloid P component
and apolipoprotein E, upon the solution behavior of
amyloid fibrils in an in vitro model system. Using ana-
lytical ultracentrifugation, electron microscopy, and
rheological measurements, we demonstrate that these
non-fibrillar components cause soluble fibrils to con-
dense into localized fibrillar aggregates with a greatly
enhanced local density of fibril entanglements. These
results suggest a possible mechanism for the observed
role of non-fibrillar components as mediators of amyloid
deposition and deposit stability.
The self-association of proteins into amyloid fibrils and the
further aggregation of these fibrils into insoluble deposits is
implicated in a diverse range of diseases, including Alzheimer’s
and other neurodegenerative diseases (1), type 2 diabetes (2),
and a number of systemic amyloidoses (3). Over twenty pro-
teins are known to form amyloid fibrils in vivo, and the deposits
formed by each of these proteins are associated with a distinct
disease state (4). Despite the lack of any similarity in primary
sequence or native structure among these precursors, the un-
derlying structures and histological properties of the deposits
are remarkably similar. The bulk of the amyloid deposit is the
amyloid fibrils themselves: linear unbranched assemblies of
the specific precursor protein with a core cross- structure (5).
Deposits also contain a number of non-fibrillar components, the
identity of which is essentially independent of the precursor
protein comprising the amyloid fibrils. These non-fibrillar com-
ponents include the protein serum amyloid P component
(SAP),1 apolipoprotein E (apoE), as well as other proteins,
glycosaminoglycans, and proteoglycans.
The ubiquity and specificity of the non-fibrillar components
of amyloid deposits is such that radiolabeled SAP is used clin-
ically as a quantitative tracer of amyloid deposits (3). Further-
more, findings that SAP stabilizes in vitro amyloid deposits
from phagocytic and proteolytic degradation has prompted the
design of inhibitors of the SAP-amyloid interaction. One such
molecule is under clinical trial against systemic amyloidosis
(6). Despite this growing clinical interest in the effects of non-
fibrillar components of amyloid deposits, structural details of
their interactions with amyloid fibrils and deposits are entirely
lacking, as are details of the mechanism by which they protect
amyloid deposits from degradation.
In vitro studies of the mechanism of amyloid fibril formation
by a number of proteins have shown it to be a complex process,
often involving a number of intermediate species and occa-
sional off-pathway aggregates. Although the relationship be-
tween this process and the pathogenic mechanisms of the amy-
loid diseases are unclear and somewhat controversial, the
distinct biological properties of the different assembly states of
amyloid fibrils are likely to be significant. For example, several
unrelated proteins, including some that are not known to form
amyloid in vivo, are cytotoxic as pre- or proto-fibrillar aggre-
gates early in the amyloid formation process but not as mature
fibrils (7–10). These findings have been taken as evidence that
all amyloid fibrils share a common cytotoxic mechanism (7),
and much recent research into the etiology of the neurodegen-
erative amyloidoses has focused upon this mechanism as an
important factor. In the case of the systemic amyloidoses, how-
ever, the major cause seems to be direct impairment of organ
function by the large amounts of insoluble material deposited
(11).
We have recently developed methodology for sedimentation
velocity analysis of amyloid fibrils and demonstrated the utility
of this approach as a probe of higher-level association of the
fibrils (12). Here we extend that work to consider the effect of
non-fibrillar components of amyloid deposits upon the associa-
tion state of amyloid fibrils. As a model system for this inves-
tigation, we have chosen the fibrils formed by human apoli-
poprotein C-II (apoC-II). Apolipoproteins are over-represented
among proteins known to form amyloid in vivo (13), and
apoC-II has been proposed as a good model for their behavior
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(14). Recent evidence implicates apoC-II amyloid fibrils in the
activation of macrophages during the development of athero-
sclerosis (15). Furthermore, apoC-II fibrils display a simple and
homogenous morphology that has been characterized in detail,
and which, importantly, is not complicated by the presence of
appreciable amounts of non-fibrillar aggregates (14). This al-
lows the hydrodynamic properties of apoC-II fibrils to be inter-
preted in terms of their association state (12). By exploiting
this property, we demonstrate an increase in fibril entangle-
ment mediated by the non-fibrillar components apoE and SAP.
The capacity of these proteins to modulate the association state
of amyloid fibrils may explain their ubiquity in amyloid depos-
its and provide insight into the mechanisms of fibril deposition
in vivo.
MATERIALS AND METHODS
Materials—ApoC-II was expressed (16) and purified (14) as described
previously. The purified protein ran as a single band on SDS-PAGE.
The purified protein stock was stored at a concentration of 40 mg/ml in
6.5 M guanidine hydrochloride, 10 mM Tris, pH 8.0 at 4 °C.
SAP was purified from human plasma (kindly provided by the Aus-
tralian Red Cross Blood Service) by affinity chromatography on single-
stranded calf thymus DNA-agarose (Amersham Biosciences). 5 ml of
DNA-agarose was washed thoroughly with 10 mM Tris, 1 M NaCl, 25 mM
Ca2, pH 7.4, and then with TNC buffer (10 mM Tris, 150 mM NaCl, 25
mM Ca2, pH 7.4). The washed resin was resuspended in 5 ml of TNC
buffer and then mixed with 250 ml of serum and stirred at room
temperature for 1 h. The resin was removed by filtration, poured into a
glass chromatography column, and washed with TNC buffer until a
steady baseline A280 nm was attained. SAP was eluted from the resin
with 10 mM Tris, 150 mM NaCl, 10 mM EDTA, pH 7.4, and then dialysed
against this buffer and concentrated to 1 mg/ml by ultrafiltration.
Purity of the preparation was confirmed by SDS-PAGE. Human ApoE3
and E4 isoforms were expressed and purified as described previously
(17).
Amyloid Fibril Preparation—ApoC-II was prepared by direct dilution
from the stock into the experimental buffer (10 mM Tris, 150 mM NaCl,
pH 7.4, with 10 mM EDTA or 2 mM Ca2, as appropriate) to a final
concentration of between 0.2–1 mg/ml apoC-II. ApoC-II freshly pre-
pared in this manner consists almost entirely of monomers (14). Amy-
loid fibrils were allowed to form by incubation of freshly prepared
apoC-II at room temperature for 3–7 days, depending upon the apoC-II
concentration.
Sedimentation Velocity Analysis—Samples were analyzed using an
XL-A analytical ultracentrifuge (Beckman Coulter, Fullerton, CA)
equipped with an AnTi60 rotor at 20 °C. Protein samples (300–400 l)
were added to double-sector epon-filled centerpieces, with refolding
buffer in the reference compartment. Radial absorbance data were
acquired at wavelengths of 280 or 292 nm, radial increments of 0.002
cm in continuous scanning mode, and rotor speeds of between 4,000–
10,000 rpm. Scans were taken at 5- or 10-min intervals. The sediment-
ing boundaries were fitted to a model describing the sedimentation of a
distribution of sedimentation coefficients with no diffusion (ls-g*(s))
using SEDFIT (18). Data were fitted using a Tikhonov-Phillips regu-
larization parameter of p  0.95, and 200 sedimentation coefficient
increments in the range of 20–3000 S, depending upon the sample.
Weight average sedimentation coefficients were calculated from the
resulting ls-g*(s) distributions using the algorithm included for this
purpose in SEDFIT (19). To correct for residual monomeric apoC-II or
free non-fibrillar components, which sediment negligibly at the rotor
speeds used, we fitted a time-independent background contribution to
the overall radial absorbance.
Bead Modeling and Determination of Sedimentation Coefficients—
The procedure for constructing bead models of apoC-II amyloid fibrils
has been described in detail previously (12). Briefly, the fibrils are
treated as worm-like chains of n linear segments, each of length l and
zero mass. Spherical beads of radius l/2 and mass m are positioned at
the vertices of the chain, where l and m are selected such that the
average volume per unit length and density of the model match that of
hydrated apoC-II fibrils. The orientation of each chain segment with
respect to the previous one is randomly determined within a normal
distribution, such that the persistence length of the chain is 36 nm,
matching that measured for apoC-II fibrils.
Protein bound to the apoC-II fibrils was treated in the following way:
additional beads were added to the model at regular distances along the
fibril, displaced from the fibril axis by a distance l. For computational
reasons, these beads must also have radius l/2 and mass m,2 corre-
sponding to a total mass of 180 kDa, 50% more than the mass of the
SAP pentamer.
In this manner, ensembles of bead models were constructed at each
of 7 lengths (44 nm, 87 nm, 170 nm, 440 nm, 870 nm, 1.7 m, and 5.2
m), and additional beads representing bound protein were added at
regular intervals to give added mass fractions of 0.02, 0.1, 0.5, 1, and 2.
The added mass fraction is given by the total mass of the additional
beads divided by the mass of the fibril prior to the addition of the
additional beads. A total of 100 bead models were constructed for each
length/added mass combination, and the sedimentation coefficient of
each model was calculated using HYDRO (20). As in our previous
method, fibril flexibility was treated by averaging the sedimentation
coefficient over each ensemble of models of identical composition but
randomly varied conformation (12).
Electron Microscopy—Copper grids (400 mesh) were coated with thin
carbon film and glow-discharged in nitrogen. Samples of apoC-II fibrils,
with or without non-fibrillar components, were applied to the grid and
allowed to equilibrate for 30 s. The samples were washed twice with
refolding buffer followed by staining with 3–4 drops of 2% potassium
phosphotungstate at pH 6.0–7.0. The grids were air-dried and exam-
ined using a JEOL 2000FX transmission electron microscope (Brooks-
vale, NSW, Australia) operating at 120 kV. Micrographs were recorded
at nominal magnifications of 40,000.
Rheology—Aliquots of 1.0 mg/ml apoC-II amyloid fibrils were incu-
bated at room temperature with 0.3 mg/ml SAP and 2 mM Ca2 for 24 h
before measurement. To obtain accurate viscoelastic profiles, solvent
viscosities were raised prior to measurement by the addition of 40%
(w/w) glycerol. The addition of glycerol caused no change in the ob-
served sedimentation behavior of the system after correction for the
change in solvent viscosity, confirming that glycerol does not affect the
structure or interactions of the fibrils. Samples were then mixed by
gentle inversion 10 times, placed on a slowly rocking platform for 30
min, and allowed to stand for 15 min. This procedure was adopted to
avoid more vigorous agitation, which had been observed to disrupt the
underlying gel-like structure of the fibril solution. Measurements were
made at 20 °C using an ARES rheometer (Rheometric Scientific, Pisca-
taway, NJ) using a cone-and-plate geometry with a 50-mm plate diam-
eter and a 42-m gap. Dynamic Strain sweeps were performed to
elucidate the linear viscoelastic region, and dynamic frequency tests
were done within this region with 2 or 5% constant strain. Steady-shear
rate tests were performed with a 10-s measurement delay and 30-s
measurement time to ensure that steady state was achieved.
RESULTS
Our initial investigations focused on the sedimentation be-
havior of 0.3 mg/ml apoC-II fibrils in the presence of varying
concentrations of non-fibrillar components of amyloid deposits
(Figs. 1 and 2). In all cases, the fibrils were observed to sedi-
ment significantly faster in the presence of non-fibrillar com-
ponents at concentrations between 0.05–0.3 mg/ml. The most
striking effect was seen in the presence of 0.3 mg/ml SAP, in
which the majority of the sample optical density had reached
the bottom of the cell within a 5-min centrifugation at 3000
rpm (data not shown). It is not possible to determine a sedi-
mentation coefficient distribution for such rapidly sedimenting
material; however, the observed behavior implies maximum
apparent sedimentation coefficients greater than 104 S. In con-
trast, SAP at the lower concentration of 0.1 mg/ml causes a
more modest increase in sedimentation coefficient, with the
weight average sedimentation coefficient increasing from 120 S
for the apoC-II fibrils alone to 171 S in the presence of SAP.
When apoE3 is added to the fibrils at a concentration of 0.025
mg/ml, an increase in average sedimentation coefficient of
slightly smaller magnitude is observed. This effect is seen to
increase systematically with apoE concentration over the range
0.025–0.075 mg/ml (Fig. 2) to a maximum weight average
sedimentation coefficient of 220 S at 0.075 mg/ml apoE. The
effect of apoE4 on the sedimentation coefficient of apoC-II
fibrils is indistinguishable from that of apoE3.
2 O. Byron, personal communication.
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Two lines of evidence point to the specificity of these effects:
(i) SAP has no effect on the sedimentation behavior of apoC-II
fibrils in the absence of calcium (Fig. 1C), and the effect in the
presence of calcium is entirely reversible with the addition of
an excess of EDTA; and (ii) serum albumin, a protein found at
high concentrations in serum but not in amyloid deposits, does
not elicit an effect on the sedimentation behavior of apoC-II
fibrils under similar conditions and at concentrations up to
0.14 mg/ml.3
Under the rotor speeds selected for these experiments, nei-
ther monomeric apoC-II nor free non-fibrillar components sed-
iment appreciably. On the other hand, non-fibrillar compo-
nents that are bound to the apoC-II fibrils will sediment with
the fibrils. Thus, if the amount of non-sedimenting material is
determined in the presence and absence of non-fibrillar com-
ponent, the difference between these two values will yield an
estimate of the amount of free non-fibrillar component in each
sample. In this way, we estimate the amount of non-fibrillar
component bound to the fibrils. At an SAP concentration of 0.1
mg/ml, 0.27 g of SAP is bound per gram of fibril, corresponding
to an approximate stoichiometry of one SAP pentamer per 50
apoC-II monomers. ApoE at 0.075 mg/ml binds at a density of
0.15 g of apoE per g of apoC-II, corresponding to a stoichiom-
etry of one apoE monomer per 40 apoC-II molecules.
To determine whether the resulting increase in sedimenta-
tion coefficient can be accounted for in terms of the increased
mass of the fibrils due to binding of non-fibrillar components,
we have modified our previous methodology for the analysis of
sedimentation coefficients of flexible fibrils (12). Bead models of
the apoC-II fibrils are constructed as before, with the addition
of extra mass and volume corresponding to the bound non-
fibrillar component. This additional mass is added to the model
fibril as discrete spherical units positioned regularly along the
fibril. This distribution of additional mass is expected to model
the frictional effects of the binding of globular proteins at
discrete positions along the fibril. We have also predicted the
change in sedimentation coefficient associated with an increase
in fibril mass using an approximate analytical solution for the
frictional properties of worm-like chains (21). This model treats
the additional mass as uniformly distributed by increasing the
radius of the cylindrical fibril and, as such, gives the maximum
possible change in sedimentation coefficient for a given mass
increase, because uniform distribution minimizes the frictional
contribution of the additional volume.
The results of both of these approaches give qualitatively3 C. L. L. Pham, G. J. Howlett, unpublished data.
FIG. 1. Sedimentation velocity of apoC-II amyloid fibrils (0.3 mg/ml)
in the absence (A) and presence (B) of 0.1 mg/ml SAP. Rotor speed was
8000 rpm, with radial absorbance scans collected at 10-min intervals.
For clarity, every second scan was omitted from the figure. C, ls-g*(s)
sedimentation coefficient distribution for apoC-II fibrils (0.3 mg/ml)
alone (solid line), in the presence of 0.1 mg/ml SAP and 10 mM EDTA
(dashed line), and in the presence of 0.1 mg/ml SAP and 2 mM Ca2
(dotted line).
FIG. 2. Sedimentation velocity of apoC-II amyloid fibrils (0.3 mg/ml)
in the absence (A) and presence (B) of 0.075 mg/ml ApoE3. Rotor speed
was 8000 rpm, with radial absorbance scans collected at 10-min inter-
vals. For clarity, every second scan was omitted from the figure. C,
ls-g*(s) sedimentation coefficient of apoC-II fibrils in the absence (solid
line), and the presence of apoE3 at 0.025 mg/ml (dashed line), 0.05
mg/ml (dotted line), and 0.075 mg/ml (dash-dot line).
SAP and apoE Mediate Tangling of Amyloid Fibrils21040
 at UQ Library on October 11, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
similar pictures of the changes to the sedimentation coefficient
because of the binding of inert mass to apoC-II fibrils. In each
case, the change in sedimentation coefficient, expressed as the
ratio of the sedimentation coefficient of the fibril with addi-
tional mass bound to the sedimentation coefficient in the ab-
sence of additional mass (s/so), is found to be approximately
linear with respect to the amount of mass bound for fibrils of
fixed length. For fibrils with a fixed amount of additional mass
(as a fraction of initial fibril mass), s/so is essentially invariant
with fibril length for fibrils longer than 500 nm.
The results from these models are compared with the exper-
imental data in Fig. 3. The experimental results are plotted as
s/so versus the mass fraction of additional protein bound to the
fibrils, with s and so values calculated as weight averages from
the sedimentation coefficient distributions in Figs. 1C and 2C,
and the mass of bound protein determined from the non-sedi-
menting optical density, as described above. Similarly, s/so is
plotted against the mass of additional protein bound to the
fibrils for the two model approaches at a fibril length of 870 nm.
It is clear from Fig. 3 that the observed changes in sedimenta-
tion coefficient are not consistent with our models, which are
based upon a simple increase in fibril mass and volume because
of the binding of non-fibrillar components. This is evident not
only from the fact that the observed changes are much larger
than predicted by any of the models; it is also suggested from
the dramatic concentration dependence observed for the SAP-
induced effect, by which SAP at 0.3 mg/ml induces increases in
the sedimentation coefficient of at least two orders of magni-
tude. This behavior is in clear contrast to the predictions of our
models, in which the relationship between s/so and mass bound
is approximately linear and has a maximal gradient of 1. As
such, the observed behavior suggests that the effect of SAP on
the sedimentation behavior of apoC-II fibrils is due to higher
order interactions between SAP and the fibrils rather than
simple one-to-one binding. Although the effect of apoE at the
concentrations studied is less dramatic than the effect of SAP
at 0.3 mg/ml, the apoE-induced changes in sedimentation co-
efficient exceed those predicted theoretically by more than a
factor of five. Thus, it is likely that both SAP and apoE promote
higher order interactions between apoC-II fibrils.
To explore the structural basis for the observed changes in
sedimentation coefficient and thus to shed light on the inter-
action of non-fibrillar components of amyloid deposits, we ex-
amined apoC-II fibrils in the presence and absence of SAP (Fig.
4) and apoE (Fig. 5) by electron microscopy. In the absence of
non-fibrillar components, apoC-II fibrils can be seen as the
long, twisted ribbons we have characterized in detail elsewhere
(14, 22), distributed in a uniform and apparently random fash-
ion over the electron microscopy grid. In the presence of SAP
and calcium, the fibrous morphology of the apoC-II remains
unchanged, and small ring-like structures can be seen bound
along the fibrils. Identical structures are seen when solutions
of SAP alone are imaged under identical conditions, and the
shape and size of these structures is consistent with that of the
SAP pentamer (23). The distribution of the fibrils in the pres-
ence of SAP and calcium is markedly different from that in the
absence of SAP, however, with the SAP-bound fibrils display-
ing a less uniform, more “clumped” distribution. Similarly, the
presence of apoE has no effect on the fibrillar morphology of
apoC-II, but instead it results in the apparent clumping or
bundling of the fibrils.
This observation raises the possibility that SAP and apoE
change the conformation or flexibility of the fibrils, and that
these changes might have an impact on the observed sedi-
mentation behavior. To address this question, we calculated
sedimentation coefficients from the analytical approximation
of Yamakawa and Fujii (21) for fibrils of varying persistence
length. This revealed that changes to the persistence length
by a factor of two produced corresponding changes in the
sedimentation coefficient of less than 25%. Thus, any small
change in persistence length that may be caused by SAP is
not likely to contribute greatly to the observed change in
sedimentation coefficient.
To relate this observation to the solution properties and
interactions of the fibrils, we performed oscillatory rheological
measurements on solutions of apoC-II fibrils in the absence and
presence of SAP. These measurements yielded the viscoelastic
spectra shown in Fig. 6. In the absence of SAP, apoC-II fibrils
behave as a very weak physical gel, with both the storage
modulus, G, and the loss modulus, G, showing only a weak
dependence upon frequency over the range measured and with
the value of G exceeding that of G over the whole range of
frequencies explored. Such behavior is consistent with a model
of the fibril solution as a network of interacting fibrils that
spans the entire solution volume. As indicated by the large
value of G, this transient network is able to efficiently store
the applied stress through conformational deformations that
subsequently relax. The frequency at which G and G are
equal in magnitude is a measure of the timescale of this me-
chanical stress relaxation in the sample. In the case of apoC-II
fibrils alone, this value lies outside of the experimentally ac-
cessible frequency range, suggesting relaxation times of at
least several seconds. The viscoelastic response of apoC-II
fibrils in the presence of SAP is markedly different to that of
the fibrils alone, with both G and G showing a decrease of
more than an order of magnitude and significantly increased
frequency dependence. Furthermore, the crossover of the loss
and storage curves is shifted to higher frequencies (30 s1),
indicating relaxation times of the order of 30 ms. The increased
rate of mechanical stress relaxation is an indication of a more
localized network structure as compared with the extensive,
gel-like network formed in the absence of SAP. The value of the
loss modulus, G, now exceeds that of G over much of the
experimental frequency range, indicating that the applied me-
chanical stress is not efficiently stored but rather is dissipated
through frictional interactions with the solvent.
To further probe this effect, we have measured the steady-
shear viscosity of apoC-II fibril solutions over a range of strain
rates in the presence and absence of SAP (Fig. 7). The degree to
which the solution viscosity decreases with increasing strain
rate (the degree of shear thinning) is a measure of the suscep-
tibility of the solution to mechanical shear. In the absence of
SAP, apoC-II fibrils are highly shear-thinning, with the viscos-
ity dropping almost an order of magnitude over two decades of
FIG. 3. Changes in sedimentation coefficient caused by bind-
ing of non-fibrillar components to apoC-II amyloid fibrils. The
change in sedimentation coefficient (s/so) is plotted against the mass
fraction of bound non-fibrillar component for apoE3 (black symbols),
SAP (white symbol), the bead model (solid line), and the analytical
model of Yamakawa and Fujii (21) (dashed line).
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strain rate to a value only slightly higher than that of the
solvent. This indicates that the network of fibril-fibril interac-
tions in the absence of SAP is weak and readily broken down by
the applied mechanical shear. The viscosity of the solution in
the presence of SAP at low strain rates is reduced by a factor of
three relative to apoC-II fibrils alone. The extent of shear-
thinning is also significantly reduced, indicating that the sys-
tem of SAP-mediated fibril-fibril interactions is less susceptible
to shear.
The observed changes in the viscoelastic properties of
apoC-II fibril solutions mediated by SAP are consistent with a
loss of the solution-spanning network of fibril-fibril interac-
tions seen in the absence of SAP. Instead, we see a shift to a
colloid-like behavior characterized by more localized networks
FIG. 4. Negatively stained electron
micrographs of apo C-II fibrils
formed at 0.3 mg/ml before (A) and
after the addition of 0.1 mg/ml SAP
(B). B, inset, magnified view of the
marked region in the center of the figure.
Arrows highlight SAP molecules bound to
the fibril. Bar, 200 nm.
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of fibril entanglements similar to microgel-like domains. This
change in solution structure can be understood as follows: in
the absence of non-fibrillar components, apoC-II fibrils are
distributed evenly throughout the solution and are extensively
cross-linked by transient interactions mediated by non-cova-
lent associations between fibrils. The fibril solution has gel-like
properties because of the resulting entangled and cross-linked
network which spans the entire solution volume. The addition
of SAP to this solution results in an increase in the number of
fibril-fibril interactions, and this increase necessarily results in
FIG. 5. Negatively stained electron micrographs of apo C-II fibrils formed at 0.4 mg/ml before (A) and after the addition of 0.05
mg/ml apoE3 (B). Bar, 200 nm.
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an increase in the local density of fibrils. As the total amount of
fibrillar material is fixed, this increase in local density in some
regions of the solution must be matched by a decrease in fibril
density over other areas. Thus, we see a condensation of small
microgel-like domains within the solution, and a decrease in
the fibril density in surrounding regions, resulting in the loss of
the solution-spanning network of fibril interactions and, thus,
a loss of the gel-like rheological properties in favor of colloid-
like behavior. Such a picture of the effect of SAP is confirmed
by the electron micrographs of apoC-II fibrils in the presence of
SAP, which show the fibrils to form discrete, condensed “bun-
dles” of many fibrils constrained by a locally dense network of
fibril entanglements. Furthermore, this change in the nature of
fibrillar entanglements offers an explanation for the observed
change in the sedimentation behavior of the fibrils, with the
localized, dense bundles of fibrils in the presence of SAP likely
to sediment considerably faster than the weak and diffuse
network of fibrillar interactions present in the absence of SAP.
DISCUSSION
An emerging theme in amyloid research centers around the
observation that early intermediates in amyloidogenesis are
cytotoxic, whereas mature fibrils and amyloid deposits, the end
points in this process, seem not to be (7–10). Such an under-
standing prompts a rather controversial rethinking of the path-
ogenic mechanisms underlying amyloid diseases, as well as
potential therapeutic strategies for these conditions. To take
the extreme position, it raises the possibility that amyloid
fibrils and, particularly, amyloid deposits might represent
adaptive mechanisms that protect the body from soluble cyto-
toxic products of protein misfolding and aggregation (24). Tra-
ditionally, however, amyloid deposits themselves have been
seen as the pathogenic species, and surgical removal of deposits
has proved an effective treatment in some cases (25). In the
light of this controversy, it is crucial to develop a better under-
standing of the mechanisms by which fibrils form and aggre-
gate into deposits.
The non-fibrillar components of amyloid deposits are impor-
tant but poorly understood factors influencing the behavior of
amyloid fibrils and deposits in vivo. The data presented here
identify and characterize a significant change in the solution
behavior of amyloid-like fibrils mediated in a general yet spe-
cific manner by SAP and apoE, two proteins known to be
non-fibrillar components of amyloid deposits in vivo. Specifi-
cally, these proteins increase the strength and density of local
fibril-fibril interactions, causing the formation of more compact
and localized fibril networks, in contrast to the weak and dis-
persed networks formed by the fibrils in the absence of these
components. This finding suggests that non-fibrillar compo-
nents of amyloid deposits may play a role in regulating the
aggregation state and solubility of amyloid fibrils by changing
the nature of fibril-fibril interactions.
Although the current findings only directly address the in-
teraction of SAP and apoE with the fibrils formed by apoC-II, a
number of lines of evidence point to the generality of the inter-
actions of SAP with amyloid fibrils: (i) SAP is found ubiqui-
tously associated with amyloid deposits in vivo, independently
of the identity of the fibril precursor protein (26); (ii) SAP binds
to all amyloid-like fibrils formed in vitro (27); and (iii) the
effects of SAP as an inhibitor of clearance of amyloid deposits
are observed in a range of in vivo and in vitro experimental
systems, again independently of the fibril precursor (6, 28–30).
Thus, it is tempting to speculate about the potential of a
broader significance for these results in terms of the interaction
of SAP with all amyloid fibrils. In particular, a role for SAP as
a regulator of the solubility of amyloid fibrils is consistent with
the observation that amyloid deposits form more slowly in mice
lacking SAP than in wild-type mice when AA amyloidosis is
induced in response to chronic inflammation (29, 30). The cur-
rent observations may also shed light on the capacity of the
non-fibrillar components to protect amyloid deposits from deg-
radation (28): the increase in fibrillar entanglements and the
resulting increase in local fibril density within deposits is likely
to limit the accessibility of fibrils to degradative machinery
such as proteases. It is particularly interesting to note that, in
addition to its interactions with amyloid fibrils, SAP also binds
to proteoglycans of the type that are also seen as components of
amyloid deposits (31). Given its pentameric structure, it is
likely that SAP is multivalent for its various binding partners,
suggesting that SAP might act as a cross-linking agent be-
tween condensed amyloid fibrils and these other non-fibrillar
components during the formation of the amyloid deposit. Such
cross-linking might further increase the density of amyloid
deposits and further enhance their resistance to clearance.
Like SAP, apoE is found ubiquitously in all amyloid deposits
(32, 33). However, with the important exception of the A
deposits associated with Alzheimer’s disease, the role of apoE
in deposit formation and persistence is very poorly studied;
even in the case of A, it remains poorly understood. There is
some evidence, however, to suggest that apoE and SAP act via
similar mechanisms to influence the formation of amyloid de-
posits (32, 34). Thus it is of some interest that apoE and SAP
elicit similar changes in the solution properties of apoC-II
amyloid fibrils, as measured by sedimentation velocity analysis
FIG. 6. Mechanical spectrum of 1 mg/ml apoC-II amyloid fibrils
in 10 mM Tris, 150 mM NaCl, 2 mM Ca2, 40% (w/w) glycerol, pH 7.4
in the presence (circles) and absence (squares) of 0.1 mg/ml SAP.
The storage modulus (G) is shown as black symbols, and the loss
modulus (G) is shown as white symbols.
FIG. 7. Steady-shear viscosity of apoC-II amyloid fibrils (1 mg/
ml) in the presence (circles) and absence (black squares) of 0.1
mg/ml SAP. The viscosity of the solvent alone (10 mM Tris, 150 mM
NaCl, 2 mM Ca2, 40% (w/w) glycerol, pH 7.4) is also shown (white
squares).
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and electron microscopy. On the other hand, it is surprising to
note that the effect of apoE on amyloid fibril entanglements is
apparently not isoform-specific. The apoE4 isoform is a major
risk factor for early onset Alzheimer’s disease, and much re-
search into A-apoE interactions have focused on differences
between the apoE2, apoE3, and apoE4 isoforms. The fact that
no such isoform-specific behavior was seen in the current study
may suggest that the interactions of apoE with apoC-II fibrils
are significantly different from those with A. On the other
hand, it may suggest that the differential effects of the apoE
isoforms on the progression of Alzheimer’s disease are not
related to differences in the apoE-amyloid interaction itself,
but rather arise from other differences in the behavior of the
apoE isoforms.
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